Ginger could cut ulcer risk, a new vaccine could protect against MRSA and could a dose of zinc silence tinnitus? | Mail Online.
A vaccine against the bug that causes MRSA could slash hospital infection rates. Early results from trials on the vaccine, named V710, show it can produce a powerful immune response that could ward off dangerous infections. It works by targeting staphylococcus aureus, the organism responsible for MRSA. Researchers tested it on 124 adults, aged 18 to 55, and found that high doses of the vaccine triggered the body’s defences into producing antibodies that can fight off invading organisms. Staphylococcus aureus is a common bug that many people carry harmlessly in their throat, nose and skin. But occasionally it gets into the bloodstream and causes MRSA, a more serious infection that is resistant to many antibiotics. Researchers found the best results came around 14 days after they injected patients with larger amounts of the vaccine — at this point 86 per cent produced an immune response.
